Skip to main content

LGMD2A clinical trials at UC Irvine

1 research study open to eligible people

Showing trials for
  • Readiness and Endpoint Assessment in LGMD R1

    open to eligible people ages 12-50

    This is a 24-month, observational study of 100 participants with Limb Girdle Muscular Dystrophy type R1, also known as CAPN3.

    Orange, California and other locations

Our lead scientists for LGMD2A research studies include .

Last updated: